Researchers review melanoma subtypes, focusing on therapeutic advances in metastatic ocular melanoma, including TILs, ImmTACs, and targeted therapies.
Enlivex Therapeutics (($ENLV)) announced an update on their ongoing clinical study. Study Overview: Enlivex Therapeutics is conducting a study ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback